Pumitamig is the class's clearest test of whether targeting PD-L1 rather than PD-1 matters. BioNTech's timelines are also the ...
Funding Will Accelerate Development of a Nanofluidic Antiretroviral Implant Designed to Deliver Continuous HIV Protection for ...
NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness ...
Takeda’s First-in-Class Narcolepsy Drug ORZEYFUL Enters Japan and China Markets Following Regulatory Approvals ...
- Celltrion, Inc. (KRX:068270) has announced its participation in the United European Gastroenterology (UEG) Week 2026 to be ...
Danaher Corporation announced a collaboration with NVIDIA to advance autonomous science and help accelerate the pace of ...
Under the terms of the agreement, Rona will receive upfront and near-term milestone payments of up to $100M and is eligible ...
CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry ...
BioAgilytix company, announced the opening of a new Australian laboratory in Sydney, expanding its national footprint to four ...
Five of the twelve Presidential Symposium late-breakers in Madrid trace back to molecules discovered in China. Here is what ...
Suvoda, a global clinical trial technology company, announced that Sofia, its AI assistant on the Suvoda Platform, is ready ...
Helfie AI ("Helfie"), an AI-powered preventive network transforming global healthcare, announced it has signed a Memorandum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results